Mosman Oil And Gas Limited (LON:MSMN) saw its shares surge on Tesday after the AIM-listed oiler reported sales revenue of US$534,000, a 191% increase on the previous six month period, while net production attributable to the company increased 35% to 4,417 barrel of oil equivalent (boe).
ValiRx Plc (LON:VAL) has won US patent protection for its pre-clinical drug VAL301, which is being developed for the treatment of endometriosis. The gynaecological disorder occurs when tissue similar to the lining of the uterus, or endometrium, migrates outside of the womb, generally to the fallopian tubes, ovaries and tissue around the uterus.
Clinigen Group PLC (LON:CLIN) added a new product to its expanding medicine cupboard and said its business was growing in line with market forecasts. In an update, the speciality pharma company told investors it was acquiring the global rights to Proleukin for an undisclosed sum from Novartis.
Silence Therapeutics PLC (LON:SLN) has announced the appointment of Dr David Horn Solomon, an experienced public company biotech boss and biotech investor as its new chief executive officer with immediate effect. The AIM-listed group, a leader in the discovery and development of novel RNA therapeutics, noted that Solomon was the CEO of Zealand Pharma A/S (NASDAQ:ZEAL) from 2008 to 2015.
Networking technologies group BATM Advanced Communications Limited (LON:BVC) is to hook up with FatPipe Networks to provide a hardware/software-agnostic solution offering real-time SD-WAN virtual network function services.
Empresaria Group plc (LON:EMR) told investors it has made an investment in Peru with a deal to acquire a 60% stake in Grupo Solimano, an outsourcing and temporary staffing business. It is paying £2.1mln for the controlling stake, comprising £1.35mln of initial cash and subsequent deferred payment.
Landore Resources Ltd (LON:LND) has intersected widespread gold mineralisation in the 900 metre gap between the two existing deposits at BAM, part of the Junior Lake property in Ontario. Among the highlights were multiple instances of visible gold.
Pembridge Resources PLC (LON:PERE) is now in the final stages of completing its 10-for-1 share consolidation, after the plan was approved at the company's annual general meeting. Pembridge will confirm the date of admission of the new shares in due course, and correspondingly, also the date of the cancellation of the old shares.
NQ Minerals PLC (NEX:NQMI) (OTCQB: NQMLF), an Australia based exploration and mining company, has announce the appointment of Kevin Puil as a non-executive director with immediate effect. The group noted that Puil currently serves as the founder and Managing Partner of RIVI Capital LLC which is a private equity fund focused on precious metals and providing investors direct access to physical metal exposure.